Clinical Outcomes of Patients With COVID19

NCT04280913 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2020-03-19

No results posted yet for this study

Summary

As of February 17th, 2020, China has 70635 confirmed cases of coronavirus disease 2019 (COVID-19), including 1772 deaths. Human-to-human spread of virus via respiratory droplets is currently considered to be the main route of transmission. The number of patients increased rapidly but the impact factors of clinical outcomes among hospitalized patients are still unclear.

Conditions

  • Coronavirus Disease 2019

Interventions

OTHER

retrospective analysis

The investigators retrospectively analyzed the hospitalized patients with COVID-19.

Sponsors & Collaborators

  • Huizhou Municipal Central Hospital

    collaborator OTHER
  • Guangzhou Institute of Respiratory Disease

    lead OTHER

Principal Investigators

  • Luqian Zhou, MD · The First Affiliated Hospital of Guangzhou Medical University

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-02-22
Primary Completion
2020-03-31
Completion
2020-03-31

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04280913 on ClinicalTrials.gov